of borderline significancep -value = 0.046
The HR was strongest in patients with no frailty (HR = 1.058, 95% CI: 1.040–1.077, p -value < 0.001) and moderate andsevere frailty (HR = 1.060, 95% CI: 1.020–1.101, p -value = 0.003), but attenuated and of borderline significance in those with mild frailty risk (HR = 1.022, 95% CI: 1.000–1.045, p -value = 0.046).